Your shopping cart is empty

Subscriber login

REGISTER FOR FREE EZINES

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

E-Zines

Check out our free and informative ezines and sign up now

Home > Newsletters > Generic Line > Teva Resolves 2009 Warning Letter for California Plant

Generic Line

Nov. 7, 2012 | Vol. 29 No. 22

Teva Resolves 2009 Warning Letter for California Plant

Teva Pharmaceuticals has resolved a long-outstanding warning letter for its Irvine, Calif., plant, the company said on its third-quarter earnings call Nov. 1.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Related Articles

FDA, USP Enlist Industry’s Help in Improving OTC Drug Quality Judge Rules Actavis’ Lialda ANDA Infringes Shire’s ‘720 Patent FDA Touts Excipient Supplier Certification Program Uniform GMPs for Excipients Right Around the Corner

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.

ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnews

All rights reserved. Do not duplicate or redistribute in any form.